Targeted attack on liver cancer: new trial tests direct drug delivery
NCT ID NCT07282509
Summary
This trial is testing a new way to deliver chemotherapy directly to liver tumors in people with advanced liver cancer that has worsened after first treatment. Doctors will thread a catheter through an artery to infuse a special form of the drug paclitaxel directly into the liver, combined with standard medications. The main goals are to see if this approach is safe and if it can help shrink or control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.